BioCentury-BayHelix China Healthcare Summit 2018

BioCentury and BayHelix Present the 5th China Healthcare Summit

China's Globally Facing Future: How China’s healthcare pathfinders are leveraging the nation’s innovation, policy initiatives and access to capital markets in HK and domestic exchanges to build a globally facing industry. Five years ago, the first China Healthcare Summit asked how the nation would build the “Bridge to Innovation.” In 2018, we examine how China is now actually building the Bridge to Global Healthcare. A full two-day program highlighted by dialog among China-facing biotech innovators and their globally-facing Chinese counterparts.

The China Summit is a VIP-only event for busy biopharma and life sciences executives and investors to get a first-hand look at the innovation, business and policy transformations taking place in China. The conference is THE place to meet the right Chinese investors and partners in an intimate setting. The China Summit will include:

  • Two days of strategic sessions and keynotes tailored to help executives understand emerging opportunities and challenges in China.
  • The China Summit report created by Insights Partner, McKinsey & Company. This exclusive analysis documents market trends and identifies business imperatives for biopharma and life sciences companies doing business in China.
  • New for 2018: For the 1st time, the China Summit will feature a presenting company track to showcase biotechs from China, Asia and the West, hand-picked by BioCentury and BayHelix.
  • New for 2018: A 1x1 meeting system will allow attendees to arrange face-to-face discussions with investors and corporate delegates.
  • Three VIP receptions to network with senior-level executives and investors.
  • The annual BayHelix Awards ceremony and lunch to celebrate R&D and commercial achievements in China.
  • Multiple networking breaks throughout the event to meet peers across the China innovation ecosystem. 

The China Summit agenda has been developed by an Organizing Committee that includes China industry KOLs and BioCentury's editorial team. Simultaneous translation is provided in all strategic sessions.

BioCentury-BayHelix China Healthcare Summit 2018

BioCentury和百华协会联合承办:第五届China Healthcare Summit。

本次峰会是为忙碌的生物制药和生命科学行业高管和投资者提供在中国发生的创新,商业和政策变化的一手信息而举办的贵宾活动。这次会议是与中国投资者和合作伙伴进行密切对话与沟通的地方。China Summit包括:

  • 为期两天的战略会议和主题演讲旨在帮助高管了解中国新兴的机遇和挑战
  • 由Insights合作伙伴麦肯锡公司创建的China Summit行业报告。这份独家分析材料记录了市场趋势和确定生物制药和生命科学公司在中国开展业务的商业需求
  • 2018年的新增:China Summit 将首次加入公司展示,包括来自中国,亚洲和西方的生物技术公司,由BioCentury和百华协会亲自挑选
  • 2018年的新增:一对一的会议系统将允许参会者安排和投资者及企业代表进行面对面的讨论
  • 三次贵宾招待会方便高层管理人员与投资者联络
  • 年度百华奖颁奖典礼和午宴,以表彰和庆祝在中国取得的研发和商业化成就
  • 会议期间有多场联谊空隙,方便与中国创新生态系统的同行互动

China Summit的会议议程由包括中国行业的关键意见领袖及BioCentury编辑团队在内的组织委员会定制。所有战略会议都提供同声传译。

View the 2018 Two-Day Agenda

View the 2018 Presenters, Speakers and Sponsors


“The healthcare industry has seen a wave of innovation and development since the COVID-19 pandemic. The new era, that comes with uncertainties and macroeconomic headwinds, requires CEOs, entrepreneurs, and all to communicate effectively and embrace innovation. BioCentury and BayHelix put together a high-quality program that really captures the latest industry trends and offers a valuable opportunity to connect with thought leaders in the region. We look forward to continuing to support the BioCentury-BayHelix China Healthcare Summit, as we have in the past, and sharing our insights at the event.”

Nisa Leung
Managing Partner
Qiming Venture Partners

"The BioCentury & BayHelix China Healthcare Summit has grown from strength to strength over the last eight years. It has become the reference China event for the biopharma community, with an increasingly global audience. As McKinsey, we are proud of our contribution to the Summit as Insights Partner, with our series of reports on “Building Bridges to Innovation”. We look forward to the ninth edition of the event. Given the current context around biotech and the biopharma industry, we expect the event to be once again a great gathering of minds to crystalize trends and shape the journey together."

Franck Le Deu
Senior Partner & Co-Leader of Asia Life Sciences Practice
McKinsey & Company